SEC Form 4 · accession 0001543077-15-000005
ARGOS THERAPEUTICS INC · ARGS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Jeffrey D Abbey
Officer — CEO · Director
Period of report
Dec 14, 2015
Accepted (ET)
Dec 17, 2015 · 11:20 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001105533
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 14, 2015 | P | 5,000 | $2.4972 | A | 10,500 | I | By IRA |
Table II — derivative securities
No Table II lines on this filing.